FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for rivastigmine tartrate submitted by Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine tartrate (rivastigmine tartrate)

Snippet

SUPPL AP for RIVASTIGMINE TARTRATE (RIVASTIGMINE TARTRATE)